论文部分内容阅读
目的观察胰激肽原酶片与复方丹参滴丸联合治疗早期糖尿病视网膜病变的临床效果。方法将30例(55眼)糖尿病视网膜病变(轻中度)患者随机分成两组,治疗组(30眼)在常规治疗基础上加用胰激肽原酶及复方丹参滴丸治疗3个月。观察治疗前后眼底、血脂、血压、糖化血红蛋白的变化。结果治疗组眼底改善较治疗组明显升高(P<0.01),血脂,血压明显下降。结论胰激肽原酶与复方丹参滴丸联合治疗糖尿病视网膜病变效果明显,且能改善血脂、血压对糖尿病患者治疗有积极意义。
Objective To observe the clinical effect of pancreatic kallikrein combined with compound Danshen dropping pills in the treatment of early diabetic retinopathy. Methods Thirty patients (55 eyes) with diabetic retinopathy (mild to moderate) were randomly divided into two groups. The treatment group (30 eyes) was treated with pancreatic kallikrein and compound Danshen dripping pills for 3 months on the basis of routine treatment. Observed before and after treatment fundus, blood lipids, blood pressure, changes in glycosylated hemoglobin. Results The improvement of fundus in treatment group was significantly higher than that in treatment group (P <0.01), blood lipid and blood pressure decreased obviously. Conclusion The combined effect of pancreatic kallikrein and compound Danshen dripping pills in the treatment of diabetic retinopathy is significant, and the improvement of blood lipids and blood pressure is of positive significance for the treatment of diabetic patients.